Familiar ETF Friend Will Enjoy a Pharmacyclics Sale
February 26, 2015 at 09:30 AM EST
Shares of Pharmacyclics (NasdaqGS: PCYC), a maker of cancer treatments, surged nearly 17% Wednesday, extending a run that has seen the stock surge 80.1% this year, on news that the California-based company is mulling a sale. Citing unidentified sources, Bloomberg reports that Dow component Johnson...